Increased vaccine sensitivity of an emerging SARS-CoV-2 variant.

Lewnard, Joseph A; Hong, Vennis; Kim, Jeniffer S; Shaw, Sally F; Lewin, Bruno; Takhar, Harpreet; Lipsitch, Marc; Tartof, Sara Y

Lewnard, Joseph A; Hong, Vennis; Kim, Jeniffer S; Shaw, Sally F; Lewin, Bruno; Takhar, Harpreet; Lipsitch, Marc; Tartof, Sara Y.

Afiliação

Lewnard JA; Division of Epidemiology, School of Public Health, , University of California, Berkeley, Berkeley, CA, 94720, USA. jLewnard@berkeley.edu.
Hong V; Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, 94720, USA. jLewnard@berkeley.edu.
Kim JS; Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, CA, 94720, USA. jLewnard@berkeley.edu.
Shaw SF; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, 91101, USA.
Lewin B; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, 91101, USA.
Takhar H; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, 91101, USA.
Lipsitch M; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, 91101, USA.
Tartof SY; Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, 91101, USA.

Nat Commun ; 14(1): 3854, 2023 06 29.

Article em En | MEDLINE | ID: mdl-37386005

Assuntos

COVID-19; Vacinas; Humanos; SARS-CoV-2/genética; Vacinas contra COVID-19; COVID-19/prevenção & controle

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google